Zhe Ruan

639 total citations
40 papers, 338 citations indexed

About

Zhe Ruan is a scholar working on Neurology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Zhe Ruan has authored 40 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 11 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Zhe Ruan's work include Myasthenia Gravis and Thymoma (22 papers), Peripheral Neuropathies and Disorders (15 papers) and Antifungal resistance and susceptibility (8 papers). Zhe Ruan is often cited by papers focused on Myasthenia Gravis and Thymoma (22 papers), Peripheral Neuropathies and Disorders (15 papers) and Antifungal resistance and susceptibility (8 papers). Zhe Ruan collaborates with scholars based in China, Slovakia and Hong Kong. Zhe Ruan's co-authors include Ting Chang, Zhuyi Li, Yonglan Tang, Kaibin Shi, Wenyan He, Handong Li, Qiang Liu, Huachen Huang, Jie Zhou and Ran Li and has published in prestigious journals such as Cell, Frontiers in Immunology and Advanced Science.

In The Last Decade

Zhe Ruan

38 papers receiving 338 citations

Peers

Zhe Ruan
Susanne Gaertner Germany
S. Ali Nabavizadeh United States
Guillaume Mathey France
Seok‐Jin Choi South Korea
Ángel I Pérez-Álvarez Spain
Johanna Oechtering Switzerland
Witold Palasik Poland
Jürgen Prestel Germany
Jae Kyu Roh South Korea
Cristina Valencia-Sánchez United States
Susanne Gaertner Germany
Zhe Ruan
Citations per year, relative to Zhe Ruan Zhe Ruan (= 1×) peers Susanne Gaertner

Countries citing papers authored by Zhe Ruan

Since Specialization
Citations

This map shows the geographic impact of Zhe Ruan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe Ruan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe Ruan more than expected).

Fields of papers citing papers by Zhe Ruan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhe Ruan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe Ruan. The network helps show where Zhe Ruan may publish in the future.

Co-authorship network of co-authors of Zhe Ruan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhe Ruan. A scholar is included among the top collaborators of Zhe Ruan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhe Ruan. Zhe Ruan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ruan, Zhe, Qingqing Wang, Chao Sun, et al.. (2025). Efficacy and Safety of Efgartigimod for Patients With Myasthenia Gravis in a Real‐World Cohort of 77 Patients. CNS Neuroscience & Therapeutics. 31(4). e70391–e70391. 2 indexed citations
3.
4.
5.
Ruan, Zhe, Yonglan Tang, Ting Gao, et al.. (2024). Efficacy and safety of tocilizumab in patients with refractory generalized myasthenia gravis. CNS Neuroscience & Therapeutics. 30(6). e14793–e14793. 8 indexed citations
6.
Ruan, Zhe, et al.. (2024). A predictive nomogram for short‐term outcomes of myasthenia gravis patients treated with low‐dose rituximab. CNS Neuroscience & Therapeutics. 30(5). e14761–e14761. 1 indexed citations
7.
Hu, Guanlian, Xue Zhao, Yiren Wang, et al.. (2024). Advances in B Cell Targeting for Treating Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis. ImmunoTargets and Therapy. Volume 13. 707–720. 1 indexed citations
8.
Su, Yue, et al.. (2023). Emerging trends and research foci of neuromyelitis optica spectrum disorder: a 20-year bibliometric analysis. Frontiers in Immunology. 14. 1177127–1177127. 8 indexed citations
9.
Zhong, Huahua, Zhe Ruan, Chong Yan, et al.. (2023). Short-term outcome prediction for myasthenia gravis: an explainable machine learning model. Therapeutic Advances in Neurological Disorders. 16. 4223436064–4223436064. 10 indexed citations
10.
Li, Shuang, Hui Liu, Zhe Ruan, et al.. (2023). Landscape analysis of m6A modification regulators related biological functions and immune characteristics in myasthenia gravis. Journal of Translational Medicine. 21(1). 166–166. 8 indexed citations
11.
Ning, Fan, et al.. (2023). Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: A systematic review and meta-analysis. Heliyon. 10(1). e23944–e23944. 3 indexed citations
12.
Ruan, Zhe, et al.. (2023). Factors associated with the disease family burden of caregivers of myasthenia gravis patients in northwestern China: A cross-sectional study. Journal of Clinical Neuroscience. 119. 70–75. 2 indexed citations
13.
Huan, Xiao, Jialin Chen, Huahua Zhong, et al.. (2023). Clinical outcome and peripheral immune profile of myasthenic crisis with omicron infections: A prospective cohort study. Clinical Immunology. 259. 109879–109879. 1 indexed citations
14.
Ruan, Zhe, Yue Su, Yonglan Tang, et al.. (2023). Nomogram for predicting the risk of postoperative myasthenic crisis in patients with thymectomy. Annals of Clinical and Translational Neurology. 10(4). 644–655. 3 indexed citations
15.
Ruan, Zhe, Xiao Huan, Yue Su, et al.. (2023). Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study. Frontiers in Immunology. 14. 1141983–1141983. 5 indexed citations
16.
Su, Yue, Zhe Ruan, Rui Wang, et al.. (2022). Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis. Frontiers in Immunology. 13. 998217–998217. 8 indexed citations
17.
Gao, Ting, Zhe Ruan, Hongyu Zhou, et al.. (2021). Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study. Neurology and Therapy. 11(1). 73–86. 12 indexed citations
18.
Zhao, Rui, Ying Wang, Xiao Huan, et al.. (2021). Nomogram for short-term outcome assessment in AChR subtype generalized myasthenia gravis. Journal of Translational Medicine. 19(1). 285–285. 6 indexed citations
19.
Ruan, Zhe, et al.. (2019). Analysis on Medication Regularity of External Prescriptions on Gout Based on Data Mining. 28(12). 2088–2090. 1 indexed citations
20.
Zhang, Shaobo, et al.. (2019). Oculoleptomeningeal amyloidosis associated with transthyretin Leu12Pro mutation in a Chinese family. Chin J Neurol. 52(5). 394–398. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne Gaertner Breakdown of academic impact, for papers by S. Ali Nabavizadeh Breakdown of academic impact, for papers by Guillaume Mathey Breakdown of academic impact, for papers by Seok‐Jin Choi Breakdown of academic impact, for papers by Ángel I Pérez-Álvarez Breakdown of academic impact, for papers by Johanna Oechtering Breakdown of academic impact, for papers by Witold Palasik Breakdown of academic impact, for papers by Jürgen Prestel Breakdown of academic impact, for papers by Jae Kyu Roh Breakdown of academic impact, for papers by Cristina Valencia-Sánchez
Rankless by CCL
2026